

eanCast: Weekly Neurology
ean.org
Official neurology podcast of the European Academy of Neurology (EAN). Expert talks on general neurology, stroke, dementia, epilepsy & many more. New episodes every Monday. For neurology residents, clinicians & researchers. A resource for continuing medical education and lifelong learning.
Episodes
Mentioned books

Nov 19, 2023 • 19min
Ep. 71: Neurological complications from cancer immunotherapy
Moderator: Antonio Malvaso
Guest: Stefania Cuzzubbo
Dr. Antonio Malva hosts Dr. Stefania Cuzzubbo to discuss neurological complications from cancer immunotherapy. Dr. Cuzzubbo highlights immune-related adverse events, focusing on peripheral nervous syst
Moderator: Antonio MalvasoGuest: Stefania CuzzubboDr. Antonio Malva hosts Dr. Stefania Cuzzubbo to discuss neurological complications from cancer immunotherapy. Dr. Cuzzubbo highlights immune-related adverse events, focusing on peripheral nervous system issues. The importance of early diagnosis using MRI, lumbar puncture, and nerve studies is emphasized. Treatment involves promptly stopping the drug and using steroids, with alternative therapies explored for steroid-refractory cases. Continued research in this evolving field is crucial.

Nov 12, 2023 • 18min
Ep. 70: Paraneoplastic neurological syndromes: diagnosis and treatment
Moderator: Antonio Malvaso (Pavia, Italy)
Guest: Alberto Vogrig (Udine, Italy)
In this episode of EAN Cast Weekly Neurology, Dr. Antonio Malvaso, a neurology resident, welcomes Dr. Alberto Vogrig, an international expert in the field of paraneoplastic neu
Moderator: Antonio Malvaso (Pavia, Italy)Guest: Alberto Vogrig (Udine, Italy)In this episode of EAN Cast Weekly Neurology, Dr. Antonio Malvaso, a neurology resident, welcomes Dr. Alberto Vogrig, an international expert in the field of paraneoplastic neurological syndromes. They discuss the definition of these syndromes, emphasizing the causal relationship with cancer and their immune-mediated pathogenesis. They also talk about the revised diagnostic criteria and the importance of clinical diagnosis, laboratory techniques, and oncologic screening. The treatment for these syndromes includes immunosuppression, cancer therapy, and symptomatic treatment, tailored to the specific symptoms.

Nov 5, 2023 • 15min
Ep. 69: A clinical approach to neurological symptoms of patients with cancer
Moderator: Alberto Vogrig (Udine, Italy)
Guest: Giulia Berzero (Milan, Italy)
In this episode Dr. Alberto Vogrig is joined by Dr. Giulia Berzero to discuss the clinical approach to neurological symptoms in patients with cancer. She highlights the increa
Moderator: Alberto Vogrig (Udine, Italy)Guest: Giulia Berzero (Milan, Italy)In this episode Dr. Alberto Vogrig is joined by Dr. Giulia Berzero to discuss the clinical approach to neurological symptoms in patients with cancer. She highlights the increasing occurrence of neurological complications in cancer patients due to improved survival rates and novel cancer treatments. Dr. Berzero emphasizes the importance of considering patient-related factors, tumor-related factors, and treatment modalities in assessing the risk of developing neurological symptoms. She also explains the signs that may prompt suspicion of brain metastasis and provides guidance on assessing and diagnosing CNS dissemination in cancer patients. Dr. Berzero stresses the need for a multidisciplinary approach and collaboration with oncologists to optimize patient care.

Oct 22, 2023 • 22min
Ep. 68: Analysis of CIDP guidelines
Moderator: Panagiotis Zis (Nicosia, Cyprus)
Guest: Peter Van den Bergh (Brussels, Belgium)
In this episode of the EAN Cast, Prof. Zis is joined by Prof. Van den Bergh to discuss the recently updated guidelines for diagnosing and treating Chronic Inflamm
Moderator: Panagiotis Zis (Nicosia, Cyprus)Guest: Peter Van den Bergh (Brussels, Belgium)In this episode of the EAN Cast, Prof. Zis is joined by Prof. Van den Bergh to discuss the recently updated guidelines for diagnosing and treating Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP). The existing guidelines were last revised over a decade ago, and this new version aims to reflect the latest advancements in clinical and basic research. Prof. Van den Bergh highlights the common pitfalls in CIDP diagnosis and emphasizes the need for accurate diagnostic criteria.The guidelines include flowcharts, tables, and criteria for different CIDP variants, as well as suggestions for supportive criteria to upgrade the diagnosis from possible CIDP to CIDP. The episode also delves into the treatment approaches, with an emphasis on corticosteroids, IVIG, and plasma exchange, and when to consider nerve biopsy.

Oct 15, 2023 • 23min
Ep. 67: EAN and WFN Brain Health Initiatives
Moderator: Thomas Berger (Vienna, Austria)
Guest: Wolfgang Grisold (Vienna, Austria)
In this podcast episode of EAN Cast, Professor Thomas Berger, Chair of the Department of Neurology at the Medical University in Vienna, and Professor Wolfgang Grisold,
Moderator: Thomas Berger (Vienna, Austria)Guest: Wolfgang Grisold (Vienna, Austria)In this podcast episode of EAN Cast, Professor Thomas Berger, Chair of the Department of Neurology at the Medical University in Vienna, and Professor Wolfgang Grisold, the current president of the World Federation of Neurology, discuss two important topics. First, they delve into the history and implementation of the World Health Organization's (WHO) Intersectoral Global Action Plan for epilepsy and other neurological disorders (ICAP). They emphasize that ICAP is a global effort to improve neurological services, and while epilepsy is a key focus, it covers various neurological disorders across countries, regardless of their income level. They highlight the importance of ICAP's five points: policy, treatment, prevention, research and innovation, and public health.Secondly, they discuss the concept of brain health, a mission closely related to ICAP, and its importance. They mention the need to raise awareness, address stigma associated with neurological diseases, and work towards individualized care for patients. They stress that these initiatives require collaboration at all levels, from global organizations to individual neurologists.

Oct 8, 2023 • 16min
Ep. 66: Classification of peripheral neuropathies
Moderator: Yıldız Değirmenci (Istanbul, Turkey)
Guest: Panagiotis Zis (Nicosia, Cyprus)
In this podcast episode Dr. Yıldız Değirmenci is joined by Dr. Panagiotis Zis to discuss peripheral neuropathies. Dr. Panagiotis Zis explains that peripheral neuropa
Moderator: Yıldız Değirmenci (Istanbul, Turkey)Guest: Panagiotis Zis (Nicosia, Cyprus)In this podcast episode Dr. Yıldız Değirmenci is joined by Dr. Panagiotis Zis to discuss peripheral neuropathies. Dr. Panagiotis Zis explains that peripheral neuropathy refers to diseases or disorders of the peripheral nerves, including mono neuropathies affecting single nerves and poly neuropathies affecting multiple nerves. The clinical symptoms of peripheral neuropathy vary depending on the type and degree of nerve fiber involvement, with symptoms ranging from pain and abnormal sensations to motor issues like muscle atrophy and cramps.Dr. Zis emphasizes the importance of a thorough neurological examination in diagnosing peripheral neuropathy and highlights key findings, such as reduced sensation, neuropathic pain, sensory ataxia, and reflex abnormalities. He also stresses the significance of electrophysiological studies, including nerve conduction studies, to confirm and classify neuropathies.The episode touches upon the classification of neuropathies based on the temporal evolution of symptoms and the involvement of large or small nerve fibers. Dr. Zis emphasizes the need to identify the cause of neuropathies, especially in chronic cases, and discusses treatment options, both pharmacological and non-pharmacological, including dietary modifications for conditions like gluten neuropathy.

Oct 1, 2023 • 23min
Ep. 65: Brain Health and Policy
Moderator: Rolf Fronczek (Leiden, The Netherlands)
Guest: Harris Eyre (Houston, USA)
Dr. Rolf Fronczek is joined by Dr. Harris Eyre to continue our discussion on the concept of Brain Health Span, emphasizing the importance of living with good brain he
Moderator: Rolf Fronczek (Leiden, The Netherlands) Guest: Harris Eyre (Houston, USA) Dr. Rolf Fronczek is joined by Dr. Harris Eyre to continue our discussion on the concept of Brain Health Span, emphasizing the importance of living with good brain health throughout life. They explore the role of neurologists in this endeavor, including individual patient care, educating other healthcare professionals, engaging in research, and participating in public policy discussions. Dr. Eyre emphasizes the need for neurologists to integrate brain health discussions into current global agendas, such as the United Nations' Sustainable Development Goals, to ensure brain health remains a prominent concern on a global scale.

Sep 24, 2023 • 23min
Ep. 64: RTC Africa
Moderator: Barbara Tettenborn (St. Gallen, Switzerland)
Guest: Erich Schmutzhard (Innsbruck, Austria), Eveline Sipido (Florence, Italy)
In this episode of "eanCast: Weekly Neurology," host Barbara Tettenborn discusses regional teaching courses in Sub-
Moderator: Barbara Tettenborn (St. Gallen, Switzerland) Guest: Erich Schmutzhard (Innsbruck, Austria), Eveline Sipido (Florence, Italy) In this episode of "eanCast: Weekly Neurology," host Barbara Tettenborn discusses regional teaching courses in Sub-Saharan Africa with special guests Professor Erich Schmutzhard and Eveline Sipido from the EAN Headoffice. These courses aim to share excellence in neurology education with residents and neurologists in Sub-Saharan Africa. They cover a range of topics, including infectious diseases of the nervous system and specific neurological conditions relevant to the region. The courses are open to a variety of healthcare professionals, not just neurologists, and are a mix of basic and specialized lectures. The episode also highlights the role of local organizers and the benefits of joining the European Academy of Neurology.

Sep 17, 2023 • 24min
Ep. 63: Neurorehabilitation of post-stroke impairments
Moderator: Sasa Filipovic (Belgrade, Serbia)
Guest: Dafin Muresanu (Cluj-Napoca, Romania)
In this final episode on Neurorehabilitation for the month, Professor Murseanu discusses the advancements and future prospects in post-stroke neurorehabilitation w
Moderator: Sasa Filipovic (Belgrade, Serbia)Guest: Dafin Muresanu (Cluj-Napoca, Romania)In this final episode on Neurorehabilitation for the month, Professor Murseanu discusses the advancements and future prospects in post-stroke neurorehabilitation with Professor Filipovic. They emphasize the importance of evidence-based medicine and personalized medicine in the field, as well as the need for real-world data and disease registers to inform and improve neurorehabilitation practices. They also discuss the impact of health policy and advocacy initiatives, such as the Stroke Action Plan for Europe, on post-stroke care and the role of economic evaluations in prioritizing interventions. The conversation highlights the ongoing research and development in various areas, including robotics, brain computer interfaces, and pharmacological interventions, to enhance stroke recovery and improve patient outcomes. The importance of collaboration between organizations and the research community is emphasized as they work towards further advancements in the field of neurorehabilitation.

Sep 10, 2023 • 23min
Ep. 62: Early neurorehabilitation
Moderator: Dafin Muresanu (Cluj-Napoca, Romania)
Guest: Karin Diserens (Lausanne, Switzerland)
In the second episode on Neurorehabilitation, Professor Muresanu is joined by Professor Diserens to discuss early neurorehabilitation. They discuss the defini
Moderator: Dafin Muresanu (Cluj-Napoca, Romania)Guest: Karin Diserens (Lausanne, Switzerland)In the second episode on Neurorehabilitation, Professor Muresanu is joined by Professor Diserens to discuss early neurorehabilitation. They discuss the definition of early neurorehabilitation, the types of patients eligible for this approach, and the evidence-based research behind it. The conversation covers topics such as mobilization programs for stroke patients, the inclusion of coma patients in the rehabilitation process, standards of treatment and program intensity, organizing the acute neurorehabilitation process, and the importance of individualized treatment based on functional consequences. The discussion concludes with a focus on financing the cost of treatment and the collaboration between European societies in advancing the field of neurorehabilitation.